China
· Delayed Price · Currency is CNY Jiangsu Nhwa Pharmaceutical Co., LTD Statistics
Total Valuation
Jiangsu Nhwa Pharmaceutical Co., LTD has a market cap or net worth of CNY 23.90 billion. The enterprise value is 20.14 billion.
| Market Cap | 23.90B |
| Enterprise Value | 20.14B |
Important Dates
The next estimated earnings date is Saturday, March 29, 2025.
| Earnings Date | Mar 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Jiangsu Nhwa Pharmaceutical Co., LTD has 1.02 billion shares outstanding. The number of shares has decreased by -0.54% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.02B |
| Shares Change (YoY) | -0.54% |
| Shares Change (QoQ) | -0.72% |
| Owned by Insiders (%) | 17.72% |
| Owned by Institutions (%) | 15.67% |
| Float | 515.98M |
Valuation Ratios
The trailing PE ratio is 20.27 and the forward PE ratio is 17.95. Jiangsu Nhwa Pharmaceutical Co., LTD's PEG ratio is 1.06.
| PE Ratio | 20.27 |
| Forward PE | 17.95 |
| PS Ratio | 4.29 |
| PB Ratio | 3.30 |
| P/TBV Ratio | 3.46 |
| P/FCF Ratio | 35.53 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.06 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.53, with an EV/FCF ratio of 29.94.
| EV / Earnings | 17.19 |
| EV / Sales | 3.64 |
| EV / EBITDA | 14.53 |
| EV / EBIT | 16.60 |
| EV / FCF | 29.94 |
Financial Position
The company has a current ratio of 6.38, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.38 |
| Quick Ratio | 5.61 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.17 |
| Interest Coverage | 289.52 |
Financial Efficiency
Return on equity (ROE) is 17.46% and return on invested capital (ROIC) is 11.18%.
| Return on Equity (ROE) | 17.46% |
| Return on Assets (ROA) | 9.93% |
| Return on Capital (ROIC) | 11.18% |
| Revenue Per Employee | 1.03M |
| Profits Per Employee | 217,164 |
| Employee Count | 5,394 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.29% in the last 52 weeks. The beta is 0.04, so Jiangsu Nhwa Pharmaceutical Co., LTD's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -11.29% |
| 50-Day Moving Average | 25.86 |
| 200-Day Moving Average | 24.74 |
| Relative Strength Index (RSI) | 29.93 |
| Average Volume (20 Days) | 6,055,994 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of CNY 5.53 billion and earned 1.17 billion in profits. Earnings per share was 1.16.
| Revenue | 5.53B |
| Gross Profit | 4.02B |
| Operating Income | 1.21B |
| Pretax Income | 1.32B |
| Net Income | 1.17B |
| EBITDA | 1.36B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | 1.16 |
Balance Sheet
The company has 3.85 billion in cash and 114.24 million in debt, giving a net cash position of 3.73 billion or 3.67 per share.
| Cash & Cash Equivalents | 3.85B |
| Total Debt | 114.24M |
| Net Cash | 3.73B |
| Net Cash Per Share | 3.67 |
| Equity (Book Value) | 7.10B |
| Book Value Per Share | 7.12 |
| Working Capital | 5.00B |
Cash Flow
In the last 12 months, operating cash flow was 1.10 billion and capital expenditures -428.13 million, giving a free cash flow of 672.72 million.
| Operating Cash Flow | 1.10B |
| Capital Expenditures | -428.13M |
| Free Cash Flow | 672.72M |
| FCF Per Share | 0.66 |
Margins
Gross margin is 72.73%, with operating and profit margins of 21.94% and 21.18%.
| Gross Margin | 72.73% |
| Operating Margin | 21.94% |
| Pretax Margin | 23.87% |
| Profit Margin | 21.18% |
| EBITDA Margin | 24.53% |
| EBIT Margin | 21.94% |
| FCF Margin | 12.16% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 1.36%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 1.36% |
| Dividend Growth (YoY) | 60.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 27.43% |
| Buyback Yield | 0.54% |
| Shareholder Yield | 1.91% |
| Earnings Yield | 4.93% |
| FCF Yield | 2.81% |
Stock Splits
The last stock split was on May 12, 2017. It was a forward split with a ratio of 1.6.
| Last Split Date | May 12, 2017 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
Jiangsu Nhwa Pharmaceutical Co., LTD has an Altman Z-Score of 17.53.
| Altman Z-Score | 17.53 |
| Piotroski F-Score | n/a |